Page last updated: 2024-10-21

1-hydroxy-3-amino-2-pyrrolidone and Peripheral Nervous System Diseases

1-hydroxy-3-amino-2-pyrrolidone has been researched along with Peripheral Nervous System Diseases in 3 studies

1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research Excerpts

ExcerptRelevanceReference
" We evaluated the ability of the functional antagonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor complex, (+)-(1-Hydroxy-3-aminopyrrolodine-2-one) ((+)-HA966), to modulate the antinociceptive action of systemic morphine in a rat model of neuropathic pain produced by chronic constriction injury to the sciatic nerve."3.70The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy. ( Christensen, D; Guilbaud, G; Idänpään-Heikkilä, JJ; Kayser, V, 1998)
"Tolerance to the analgesic effect of morphine complicates the management of chronic pain states."3.70Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats. ( Christensen, D; Guilbaud, G; Kayser, V, 2000)
"Thermal hyperalgesia to radiant heat was assessed by using a foot-withdrawal test and NMDA/non-NMDA receptor antagonists were administered intrathecally onto the lumbar spinal cord before and after nerve injury."1.28Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. ( Hayes, RL; Lu, J; Mao, J; Mayer, DJ; Price, DD, 1992)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christensen, D2
Idänpään-Heikkilä, JJ1
Guilbaud, G2
Kayser, V2
Mao, J1
Price, DD1
Hayes, RL1
Lu, J1
Mayer, DJ1

Other Studies

3 other studies available for 1-hydroxy-3-amino-2-pyrrolidone and Peripheral Nervous System Diseases

ArticleYear
The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    British journal of pharmacology, 1998, Volume: 125, Issue:8

    Topics: Analgesics, Opioid; Animals; Binding Sites; Cold Temperature; Disease Models, Animal; Dose-Response

1998
Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
    Anesthesiology, 2000, Volume: 92, Issue:3

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Drug Tolerance; Excitatory Amino Acid Antagonists; In

2000
Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.
    Brain research, 1992, Dec-11, Volume: 598, Issue:1-2

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Dizocilpine Maleate; Hot Temperature; Hyperalgesia; I

1992